Literature DB >> 28726796

Three-year change in endothelin-1 and markers of vascular remodelling in a bi-ethnic South African cohort: the SABPA study.

C S du Plooy1, C M C Mels1,2, H W Huisman1,2, R Kruger1,2.   

Abstract

South Africans are at high risk for developing cardiovascular disease. Endothelin-1 is known for its vasoconstrictive properties and its ability to contribute to vascular structural changes. In this study we investigated the association of change in endothelin-1 levels and change in markers implicated in vascular remodelling after 3 years. Serum endothelin-1 levels and markers of vascular remodelling such as carotid intima-media thickness, carotid cross-sectional wall area (CSWA) and arterial compliance were measured. Participants were divided into two groups according to an increase (n=185) and a decrease (n=152) in plasma endothelin-1 levels after 3 years. In partial regression analysis, the extent of endothelin-1 increase correlated positively with a change in pulse pressure and inversely with the change in arterial compliance in the group with increased endothelin-1 levels after 3 years. In the group with decreased endothelin-1 levels, the extent of decreased endothelin-1 correlated inversely with a change in CSWA. In multiple regression analysis, after splitting for race, the increase in endothelin-1 levels associated positively with the change in pulse pressure (Adj. R2=0.092; β=0.278; P=0.036) in the black participants only. In conclusion, with increased endothelin-1 levels after 3 years, the positive association between endothelin-1 and pulse pressure suggest subclinical haemodynamic changes with potential premature onset of cardiovascular disease in the black participants.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28726796     DOI: 10.1038/jhh.2017.47

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  32 in total

1.  European Society of Hypertension position paper on ambulatory blood pressure monitoring.

Authors:  Eoin O'Brien; Gianfranco Parati; George Stergiou; Roland Asmar; Laurie Beilin; Grzegorz Bilo; Denis Clement; Alejandro de la Sierra; Peter de Leeuw; Eamon Dolan; Robert Fagard; John Graves; Geoffrey A Head; Yutaka Imai; Kazuomi Kario; Empar Lurbe; Jean-Michel Mallion; Giuseppe Mancia; Thomas Mengden; Martin Myers; Gbenga Ogedegbe; Takayoshi Ohkubo; Stefano Omboni; Paolo Palatini; Josep Redon; Luis M Ruilope; Andrew Shennan; Jan A Staessen; Gert vanMontfrans; Paolo Verdecchia; Bernard Waeber; Jiguang Wang; Alberto Zanchetti; Yuqing Zhang
Journal:  J Hypertens       Date:  2013-09       Impact factor: 4.844

2.  Wall shear stress in the human common carotid artery as function of age and gender.

Authors:  S K Samijo; J M Willigers; R Barkhuysen; P J Kitslaar; R S Reneman; P J Brands; A P Hoeks
Journal:  Cardiovasc Res       Date:  1998-08       Impact factor: 10.787

3.  The white coat effect is not associated with additional increase of target organ damage in true resistant hypertension.

Authors:  Valéria Nasser Figueiredo; Luiz Cláudio Martins; Leandro Boer-Martins; Ana Paula Cabral de Faria; Carolina de Haro Moraes; Rodrigo Cardoso Santos; Armando R Nogueira; Heitor Moreno
Journal:  Med Clin (Barc)       Date:  2012-09-17       Impact factor: 1.725

4.  Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.

Authors:  A Zanchetti; M G Bond; M Hennig; A Neiss; G Mancia; C Dal Palù; L Hansson; B Magnani; K H Rahn; J Reid; J Rodicio; M Safar; L Eckes; R Ravinetto
Journal:  J Hypertens       Date:  1998-07       Impact factor: 4.844

5.  High-throughput spectrophotometric assay of reactive oxygen species in serum.

Authors:  Ikue Hayashi; Yukari Morishita; Kazue Imai; Masakazu Nakamura; Kei Nakachi; Tomonori Hayashi
Journal:  Mutat Res       Date:  2007-04-20       Impact factor: 2.433

6.  Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension.

Authors:  S Ergul; D C Parish; D Puett; A Ergul
Journal:  Hypertension       Date:  1996-10       Impact factor: 10.190

7.  Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction.

Authors:  Farhad Amiri; Agostino Virdis; Mario Fritsch Neves; Marc Iglarz; Nabil G Seidah; Rhian M Touyz; Timothy L Reudelhuber; Ernesto L Schiffrin
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

Review 8.  Endothelin: potential role in hypertension and vascular hypertrophy.

Authors:  E L Schiffrin
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

9.  The association of endothelin-1 with markers of oxidative stress in a biethnic South African cohort: the SABPA study.

Authors:  Christine Susara du Plooy; Catharina Martha Cornelia Mels; Hugo Willem Huisman; Ruan Kruger
Journal:  Hypertens Res       Date:  2016-09-29       Impact factor: 3.872

10.  Elevated endothelin-1 levels are associated with decreased arterial elasticity in hypertensive patients.

Authors:  Adviye Ergul; Dena Jupin; Maribeth H Johnson; L Michael Prisant
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-08       Impact factor: 3.738

View more
  1 in total

1.  Association of C-Terminal Pro-Endothelin-1 with Mortality in the Population-Based KORA F4 Study.

Authors:  Cornelia Then; Chaterina Sujana; Christian Herder; Holger Then; Margit Heier; Christa Meisinger; Annette Peters; Wolfgang Koenig; Wolfgang Rathmann; Haifa Maalmi; Katrin Ritzel; Michael Roden; Michael Stumvoll; Barbara Thorand; Jochen Seissler
Journal:  Vasc Health Risk Manag       Date:  2022-05-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.